LAUREL BIOTHERAPEUTICS Trademark
Trademark Overview
On Wednesday, July 31, 2024, a trademark application was filed for LAUREL BIOTHERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the LAUREL BIOTHERAPEUTICS trademark a serial number of 98675319. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Wednesday, July 31, 2024. This trademark is owned by Laurel Biotherapeutics, Inc.. The LAUREL BIOTHERAPEUTICS trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:
House mark for a line of antibodies for medical purposes; house mark for a line of pharmaceutical preparations for the treatment and prevention of heart disease and other diseases; house mark for a line of therapeutic pharmaceuticals for the treatment of heart disease and other diseases
Pharmaceutical products development; Pharmaceutical research services; Research and development in the field of antibody therapeutics for the treatment of heart diseases and other diseases for medical purposes; Research and development in the pharmaceutical and biotechnology fields; Research and development services in the field of antibodies; Research and development services of new pharmaceutical products
General Information
| Serial Number | 98675319 |
| Word Mark | LAUREL BIOTHERAPEUTICS |
| Filing Date | Wednesday, July 31, 2024 |
| Status | 630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER |
| Status Date | Wednesday, July 31, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Goods and Services | House mark for a line of antibodies for medical purposes; house mark for a line of pharmaceutical preparations for the treatment and prevention of heart disease and other diseases; house mark for a line of therapeutic pharmaceuticals for the treatment of heart disease and other diseases |
| NOT AVAILABLE | BIOTHERAPEUTICS |
| Goods and Services | Pharmaceutical products development; Pharmaceutical research services; Research and development in the field of antibody therapeutics for the treatment of heart diseases and other diseases for medical purposes; Research and development in the pharmaceutical and biotechnology fields; Research and development services in the field of antibodies; Research and development services of new pharmaceutical products |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, July 31, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, July 31, 2024 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Laurel Biotherapeutics, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Woburn, MA 01801 |
Trademark Events
| Event Date | Event Description |
| Wednesday, July 31, 2024 | NEW APPLICATION ENTERED |
| Wednesday, November 13, 2024 | TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED |
| Wednesday, November 13, 2024 | TEAS VOLUNTARY AMENDMENT RECEIVED |
